FDA decisions are pivotal for our clients and the people with diabetes they serve. At dQ&A, we’ve recently been involved in helping our clients create rigorous patient preference research packages for inclusion with FDA submissions. In this note, I’d like to give you some insight on why and how we are doing this exciting work…
dQ&A’s European Patient Panel…
dQ&A was honored to participate in the 2019 ADA Scientific Sessions…
Millions of people with diabetes…
We wanted to know how grocery stores perform in terms of their diabetes-friendliness…
It’s important to be sure you have high quality answers before making important clinical or commercial…
We looked back at the 10-year trends in drug and device penetration in the dQ&A Community…
